These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4402099)

  • 41. Effect of five beta-adrenoceptor antagonists on the effect of isoprenaline and acetylcholine on human isolated smooth muscle.
    Hedges A; Turner P
    Br J Pharmacol; 1971 Feb; 41(2):426P-427P. PubMed ID: 4396707
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 43. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 44. Steric aspects of adrenergic drugs. 8. Optical isomers of beta adrenergic receptor antagonists.
    Patil PN
    J Pharmacol Exp Ther; 1968 Apr; 160(2):308-14. PubMed ID: 4384787
    [No Abstract]   [Full Text] [Related]  

  • 45. [Influence of some drugs with adrenergic beta-receptor blocking action on the repolarization phase of the electrocardiogram of normal subjects].
    Barbaresi F; Volta G; Starcich R
    Folia Cardiol; 1969; 28(1):1-6. PubMed ID: 4391631
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardioselective beta-adrenergic blockade.
    Fitzgerald JD
    Proc R Soc Med; 1972 Sep; 65(9):761-4. PubMed ID: 4404402
    [No Abstract]   [Full Text] [Related]  

  • 47. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 48. Raised serum-lipids unaffected by beta-blockade.
    Lloyd-Mostyn RH; Krikler DM
    Lancet; 1970 Nov; 2(7681):1040. PubMed ID: 4098084
    [No Abstract]   [Full Text] [Related]  

  • 49. Structure-activity relationship of the beta adrenoreceptor blocking agents.
    Laddu AR; Somani P
    Eur J Pharmacol; 1969 Nov; 8(2):167-70. PubMed ID: 4391503
    [No Abstract]   [Full Text] [Related]  

  • 50. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.
    Levy JV
    Eur J Pharmacol; 1968 Feb; 2(4):250-7. PubMed ID: 4384450
    [No Abstract]   [Full Text] [Related]  

  • 51. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines.
    Ablad B; Brogård M; Carlsson E; Ek L
    Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676
    [No Abstract]   [Full Text] [Related]  

  • 52. Beta-adrenergic blocker, 2-(2-hydroxy-3-tert-butylaminopropoxy) chlorobenzene hydrochloride (D-69-12).
    Takagi K; Takayanagi I; Kaziwara Y; Hiramatsu Y; Izumi A
    Jpn J Pharmacol; 1970 Dec; 20(4):504-8. PubMed ID: 4395620
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
    Singh BN; Williams EM
    Br J Pharmacol; 1971 Sep; 43(1):10-22. PubMed ID: 4400181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion.
    Westfall TC
    Eur J Pharmacol; 1967 Dec; 2(3):163-8. PubMed ID: 5591515
    [No Abstract]   [Full Text] [Related]  

  • 58. [Influence of an alpha- and beta-receptor blockade on the dynamics of insulin secretion in dogs following increased dosage of various sulfonylureas].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():1069-72. PubMed ID: 4405360
    [No Abstract]   [Full Text] [Related]  

  • 59. [Which beta-adrenergic agent should be used for the inhibition of labor (Berotec, Ritodrine, Dilatol)?].
    Hüter J; Rippert C; Meyer C
    Geburtshilfe Frauenheilkd; 1972 Feb; 32(2):97-103. PubMed ID: 4401339
    [No Abstract]   [Full Text] [Related]  

  • 60. [Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride].
    Rosak C; Bartelt KM; Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2181. PubMed ID: 4146791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.